Investing in the Future of Cannabis.
A strengthened balance sheet. A growing global platform. And a clear strategy to lead the world’s next major consumer category.
WHY INVEST IN CANOPY GROWTH
Canopy Growth is building a global platform focused on quality, consistency, and consumer trust. Our scale, strategy, and belief in cannabis drive long-term value for shareholders.
Overview
Most Recent Earnings
Q1 FY2027 Earnings Results
August 07, 2026
Net Revenue Growth
+13%
Canada Medical Cannabis
+22%
International Cannabis
+10%
Canopy Growth’s momentum continues into fiscal 2027 with net revenue growth in every business and improving profitability.
Industry Leadership
Canada’s #1 medical cannabis company by revenue, with a nationwide clinic network, and top three positions in adult-use premium flower, infused pre-rolls, and oils and softgels.
Cultivation Excellence
Disciplined, repeatable processes for producing high-quality cannabis consistently at scale to service global markets.
Global Growth Platform
European operations anchored in Germany with expansion into new markets underway.
Financial Strength
A strong net cash position with debt maturities extended to 2031.
Experienced Leadership
Disciplined operators with deep experience across cannabis, consumer goods, and global markets.
investor contact
Reach out to our investor relations team
